pharmacodynamic biomarkers for biosimilar development and approval: day 1
Published 2 years ago • 954 plays • Length 3:35:15Download video MP4
Download video MP3
Similar videos
-
3:42:11
pharmacodynamic biomarkers for biosimilar development and approval: day 2
-
9:50
the role of pharmacodynamic biomarkers in biosimilar drug development
-
3:28:05
translational science in drug development: surrogate endpoints, biomarkers, and more - day 1
-
4:20
the biosimilar development process
-
4:12
the basics of biosimilars
-
14:19
regulatory pathway for biosimilars
-
1:45
what is a biosimilar? - video explainer
-
28:55
blending biophysics and machine learning to predict the antibody response -tal einav, ph.d.
-
5:47
how biomarkers can improve the drug development process
-
1:42
biosimilars vs. interchangeable biosimilars: what’s the difference?
-
7:22
an overview of biosimilarity
-
18:36
development and validation of cerebrospinal fluid & blood biomarkers for neurodegenerative diseases
-
3:07
the promise of biosimilars
-
13:53
biomarkers expression - indicator of platelet activation in diff biocompatible circuit coating
-
5:20
data requirements for biosimilars
-
4:07:59
translational science in drug development: surrogate endpoints, biomarkers, and more - day 2
-
2:05
what are biomarkers and why are they important?